Pfizer: 3 doses of vaccine neutralize omicron; 2 doses less effective
Pfizer announced this morning that results from an initial laboratory study show that three doses of its COVID-19 vaccine neutralize the omicron variant, while two doses were significantly less effective.
News 12 Staff
•
Dec 8, 2021, 12:21 PM
•
Updated 862 days ago
Share:
More Stories
Hometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
48ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
69ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
196ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
196ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
199ds agoHometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
48ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
69ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
196ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
196ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
199ds agoPfizer announced Wednesday morning that results from an initial laboratory study show that three doses of its COVID-19 vaccine neutralize the omicron variant, while two doses were significantly less effective.
The study showed that two doses will still protect you from severe disease, but three doses had the power to neutralize the variant.
The latest data shows the booster raised antibody levels a staggering 25 times.
The news comes as the two companies confirm their variant vaccine for omicron will be ready in March.
The companies confirm they still don't know if that variant vaccine will be needed, and they are doing more tests as well as keeping an eye on real world effectiveness.
The omicron variant, which so far seems to cause mild symptoms, surfaced in multiple states, with more than a dozen cases in New York, including the first Hudson Valley case confirmed this week.
The omicron variant, which so far seems to cause mild symptoms, surfaced in multiple states, with more than a dozen cases in New York, including the first Hudson Valley case confirmed this week.
